Subscribe for great stories in your community!
Global biotherapeutics leader CSL Behring, located in King of Prussia, announced that it will proceed with a global Phase 3 cardiovascular morbidity and mortality trial…
Before we send you to this site, please subscribe to our daily newsletter.